Study to Assess Safety and Immunogenicity of an Egg-based H5N8 Influenza Vaccine at Multiple Dose Levels Adjuvanted With Matrix-M in Healthy Participants 18 Years of Age and Above.

Recruiting

Plain-English translation of NCT07779408 on ClinicalTrials.gov ↗ · Source last updated September 2026 · How we translate trials

Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.

Trial locations(16 sites)

United States

AMR Clinical Phoenix, Arizona- Site Number : 8400004, Tempe, Arizona

Peninsula Research Associates- Site Number : 8400011, Rolling Hills Estates, California

California Research Foundation- Site Number : 8400007, San Diego, California

Alliance for Multispeciality Research - Coral Gables- Site Number : 8400003, Coral Gables, Florida

Accel Research Sites Network - DeLand Clinical Research Unit- Site Number : 8400017, DeLand, Florida